|
|
|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
|
Mineralys Therapeutics, Inc. (MLYS) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
| |
Company
Roster
|
|
Total
Insiders : |
10 |
|
|
|
Total
Direct Shares :
|
3,964,044 |
|
|
Total
Indirect Shares :
|
27,165,655 |
| |
%
Held by Insiders:
|
2.96% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Congleton Jon |
Chief Executive Officer, Director |
2025-11-21 |
655,387 |
|
0 |
Gold Alexander M |
Director |
2025-11-13 |
0 |
2025-11-11 |
0 |
Karydas Daphne |
Director |
2025-11-13 |
0 |
2025-11-13 |
0 |
Levy Adam Scott |
CFO and Secretary |
2025-11-11 |
19,396 |
|
0 |
Rodman David Malcom |
Chief Medical Officer |
2025-10-15 |
71,155 |
2023-08-10 |
0 |
Akkaraju Srinivas |
|
2024-02-12 |
0 |
2025-09-04 |
6,263,151 |
Hbm Bioventures Cayman Ltd |
10% Owner |
2023-02-14 |
3,218,106 |
2023-02-14 |
0 |
Samsara Biocapital, L.p. |
10% Owner |
2023-02-14 |
0 |
2025-03-13 |
5,674,916 |
Shah Rajeev M. |
Director |
2023-02-14 |
0 |
2025-09-04 |
7,323,750 |
Catalys Pacific Fund, Lp |
10% Owner |
|
0 |
2025-11-20 |
7,903,838 |
|
|